Palmitoyl transferases act as novel drug targets for pancreatic cancer

BACKGROUND: Pancreatic adenocarcinoma (PAAD) is one of the most leading causes of cancer-related death across the world with the limited efficiency and response rate of immunotherapy. Protein S-palmitoylation, a powerful post-translational lipid modification, is well-known to regulate the stability...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Zhiqing, Lv, Ziru, Liu, Xin, Huang, Keke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084701/
https://www.ncbi.nlm.nih.gov/pubmed/37038141
http://dx.doi.org/10.1186/s12967-023-04098-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084701/
https://www.ncbi.nlm.nih.gov/pubmed/37038141
http://dx.doi.org/10.1186/s12967-023-04098-3

Ejemplares similares